Longevity Bros
Home › Glossary › IGF-1
Glossary

IGF-1: the growth marker with a U-shaped curve, and the range to aim for

IGF-1 is the number that makes the growth-versus-longevity trade-off visible on a lab report. Too little and muscle and bone suffer; too much and cancer and mortality risk rise. The middle is the target.

Reviewed by the Longevity Bros team · Updated 1 October 2026

Before you read onResearch and educational information for adults, not medical advice. This entry explains one longevity term — what it means, why it matters and what the evidence says — and nothing here diagnoses, treats, cures or prevents any condition. Baseline labs come before anything, and your own physician has the final word. Longevity Bros offers coaching and written research protocols only — we do not sell, supply, source or ship any compound.

What it means

Insulin-like growth factor 1 is a peptide made mainly by the liver in response to growth hormone, and it carries out most of GH's anabolic effects: muscle protein synthesis via mTOR, bone growth, cell proliferation. It is a stable, once-a-day measure of GH activity, which is why it is the lab test for the GH axis rather than GH itself (which pulses).

Levels peak in adolescence and fall about 15% per decade; protein intake, insulin, sleep and training raise them, fasting and calorie restriction lower them.

Why it matters for longevity

Reduced IGF-1 signalling extends lifespan in every lab organism, and people with rare IGF-1 deficiency (Laron syndrome) almost never get cancer or diabetes. Yet low IGF-1 in ordinary older adults predicts frailty, sarcopenia and cardiovascular death. Both are true, which is why the relationship is U-shaped and the practical question is where on the curve to sit.

What the evidence says

Burgers 2011 meta-analysis (12 cohorts) and the EPIC and UK Biobank data show a U-shaped curve: all-cause mortality lowest in the middle of the range and higher at both extremes. High IGF-1 is associated with breast, prostate and colorectal cancer (pooled relative risk around 1.2–1.5 for top versus bottom quintile). Low IGF-1 is associated with heart failure, frailty and ischaemic stroke.

Interventions: protein intake above 1.2 g/kg raises IGF-1 by 10–20% (Levine 2014 argued for lower protein in mid-life on this basis, with higher intake after 65); fasting lowers it within days; secretagogues raise it within weeks. No trial has targeted IGF-1 for a longevity outcome.

How to measure or use it

Related

Frequently asked questions

What is a good IGF-1 level?

Mid-range for your age is the usual target — roughly 150–250 ng/mL over 40. Both extremes carry risk; the curve is U-shaped.

Does protein raise IGF-1?

Yes, by about 10–20% at intakes above 1.2 g/kg. After 65 that is probably protective; in mid-life, opinions differ.

Is high IGF-1 dangerous?

Persistently high levels are associated with several cancers and higher mortality. Anything that raises IGF-1 should have a ceiling and a retest.

Your own protocol

Want this applied to your own numbers?

Fifteen minutes of intake, your labs, a human-reviewed protocol within about 24 hours, three documents, a free coach call and check-ins through the cycle. €399, follow-up included.

Build my protocol Book a 15-minute call